Trial Outcomes & Findings for Study Comparing Fit of the iTotal Versus Standard Total Knee Implants (NCT NCT01861028)

NCT ID: NCT01861028

Last Updated: 2023-10-25

Results Overview

Fit will be measured in 4 quadrants on the tibia using a ruler to measure the distance between the customized implant and the edge of the tibia.

Recruitment status

TERMINATED

Target enrollment

44 participants

Primary outcome timeframe

Intraoperatively, up to 120 minutes

Results posted on

2023-10-25

Participant Flow

Participant milestones

Participant milestones
Measure
iTotal CR TKR
A series of 44 consecutive primary iTotal patients will be compared to assess the fit of the tibial tray intra-operatively. These patients will have a series of tibial templates from Standard TKR implant sets trialed on the operative knee. Each template will be optimally sized and positioned based on the surgeon's judgment. Implant fit data (overhang and underhang) on the tibia for all templates will be taken from intra-operative measurements
Overall Study
STARTED
44
Overall Study
COMPLETED
44
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Study Comparing Fit of the iTotal Versus Standard Total Knee Implants

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
iTotal CR TKR
n=44 Participants
A series of 44 consecutive primary iTotal patients will be compared to assess the fit of the tibial tray intra-operatively. These patients will have a series of tibial templates from Standard TKR implant sets trialed on the operative knee. Each template will be optimally sized and positioned based on the surgeon's judgment. Implant fit data (overhang and underhang) on the tibia for all templates will be taken from intra-operative measurements
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
n=99 Participants
Age, Categorical
>=65 years
32 Participants
n=99 Participants
Age, Continuous
70.48 Years
n=99 Participants
Sex/Gender, Customized
Women
17 Participants
n=99 Participants

PRIMARY outcome

Timeframe: Intraoperatively, up to 120 minutes

Population: 44 consecutive primary iTotal patients - number of patients with overhang of 3mm or more

Fit will be measured in 4 quadrants on the tibia using a ruler to measure the distance between the customized implant and the edge of the tibia.

Outcome measures

Outcome measures
Measure
Phase I
n=44 Participants
A series of 44 consecutive primary iTotal patients will be compared to assess the fit of the tibial tray intra-operatively. These patients will have a series of tibial templates from Standard TKR implant sets trialed on the operative knee. Each template will be optimally sized and positioned based on the surgeon's judgment. Implant fit data (overhang and underhang) on the tibia for all templates will be taken from intra-operative measurements
Phase I: Number of Participants With a Customized Tibia Implant Displaying an Overhang of 3 mm or Greater
0 Participants

PRIMARY outcome

Timeframe: Intraoperatively, up to 120 minutes

Population: 44 consecutive primary iTotal patients - number of patients with overhang of 3mm or more

Fit will be measured in 3 quadrants on the tibia using a ruler to measure the distance between the off-the-shelf design and the edge of the tibia.

Outcome measures

Outcome measures
Measure
Phase I
n=44 Participants
A series of 44 consecutive primary iTotal patients will be compared to assess the fit of the tibial tray intra-operatively. These patients will have a series of tibial templates from Standard TKR implant sets trialed on the operative knee. Each template will be optimally sized and positioned based on the surgeon's judgment. Implant fit data (overhang and underhang) on the tibia for all templates will be taken from intra-operative measurements
Phase II: Number of Participants With an Off-the-Shelf Implant Displaying an Overhang of 3 mm or Greater
8 Participants

Adverse Events

Enrolled Subjects

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Director of Clinical and Technical Research

Conformis

Phone: 781-345-9103

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place